Amerikanische Gesellschaft für Hirudotherapie

Leech (Hirudo medicinalis) Therapy for the Treatment of Nipple-Areolar Complex Congestion Following Breast Reduction

Freeman M, Carney M, Matatov T, Vemula R, Babycos C (2015) · Eplasty · n=1

RCT evidence detailTrial reference
GRADE Very LowInsufficient evidenceCondition: Breast Reconstruction Flap Salvage
Sample size of this trial compared with other Breast Reconstruction Flap Salvage trialsRajaram R 202428Maetz B 20122Freeman M 20151Moffat AD 20151Torresetti M 20241Baccarani A 20221
This trial (highlighted) by sample size alongside other indexed Breast Reconstruction Flap Salvage trials. Larger trials generally carry more statistical weight.

Study Profile

Design
single-center case report of leech therapy for nipple-areolar complex (NAC) venous congestion after reduction mammaplasty (Department of Surgery, Division of Plastic and Reconstructive Surgery, Tulane University School of Medicine, New Orleans, USA)
Sample size (n)
1
Intervention
Hirudo medicinalis leech application for venous congestion of the nipple-areolar complex (NAC) after reduction mammaplasty; standard protocol with prophylactic antibiotic coverage
Comparator
Not applicable - single-patient case report; comparison to alternative methods of NAC congestion management is narrative only
Primary endpoint
Resolution of NAC venous congestion and preservation of NAC viability following reduction mammaplasty
Primary result
Case demonstrates feasibility of leech therapy for NAC venous congestion after breast reduction mammaplasty; congestion resolution and NAC viability preservation achieved; case illustrates the broader applicability of leech therapy beyond microsurgical free-flap salvage to include pedicled flap and reduction mammaplasty complications
Follow-up duration
case-specific NAC viability monitoring period

Key Findings

  • Documents successful leech therapy for nipple-areolar complex venous congestion after reduction mammaplasty in a US academic center
  • Demonstrates that K040187-cleared leech therapy applies beyond free-flap salvage to include NAC congestion in reduction mammaplasty
  • Adds breast-reduction-specific evidence to the broader breast-surgery leech therapy literature
  • Reinforces the standard prophylactic-antibiotic protocol for breast leech applications
  • Tulane University case adds Southern US geographic representation to the leech-therapy evidence base

Limitations

  • Single case (n=1) - cannot establish incidence or generalizable efficacy
  • No randomized comparator or alternative-treatment arm
  • Outcome documentation limited to short-term NAC viability
  • Long-term cosmetic and functional outcomes not reported in abstract
  • Selection bias - successful case reports tend to be over-represented in case series

Clinical Implications

Freeman 2015 documents successful use of leech therapy for nipple-areolar complex venous congestion after breast reduction mammaplasty in a US academic center. For US clinicians, the case supports the broader application of K040187-cleared leech therapy beyond free-flap microsurgery to include pedicled breast surgery complications. The case is included in the registry to document the breadth of US plastic-surgery experience with leech therapy. It does not provide controlled-outcome evidence and should be cited alongside other breast leech reports (Moffat 2015, Torresetti 2024) to give a balanced view of both efficacy signals and safety concerns.

Related Trials

Diese Website stellt Bildungsinformationen bereit und ist weder eine medizinische Beratung noch eine Diagnose oder Behandlungsempfehlung. Die medizinische Blutegeltherapie ist mit klinisch relevanten Risiken verbunden und sollte ausschließlich von qualifizierten Klinikerinnen und Klinikern unter institutionell genehmigten Protokollen durchgeführt werden. Die FDA-510(k)-Zulassung für medizinische Blutegel ist auf bestimmte Indikationen beschränkt; experimentelle und Off-Label-Diskussionen werden entsprechend gekennzeichnet. Für patientenspezifische Beratung wenden Sie sich an eine qualifizierte Gesundheitsfachkraft.